---
title: "RQM+ Launches SMART Solutions Life Cycle Partnership Model"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/278897850.md"
description: "In Pittsburgh, a top MedTech CRO called RQM+ unveiled SMART Solutions, a new life cycle partnership model tailored to aid medical device and diagnostics firms in navigating the increasing complexity of regulations and development processes. This framework integrates regulatory, quality, clinical, reimbursement, and laboratory services to provide comprehensive support. RQM+ specializes in regulatory consulting, clinical trials, laboratory services, and reimbursements, and this initiative aims to assist companies in managing these processes effectively.SMART Solutions aims to streamline operations and provide strategic guidance for MedTech companies amidst evolving regulatory landscapes."
datetime: "2026-03-12T13:37:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278897850.md)
  - [en](https://longbridge.com/en/news/278897850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278897850.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/278897850.md) | [English](https://longbridge.com/en/news/278897850.md)


# RQM+ Launches SMART Solutions Life Cycle Partnership Model

In Pittsburgh, a top MedTech CRO called RQM+ unveiled SMART Solutions, a new life cycle partnership model tailored to aid medical device and diagnostics firms in navigating the increasing complexity of regulations and development processes. This framework integrates regulatory, quality, clinical, reimbursement, and laboratory services to provide comprehensive support. RQM+ specializes in regulatory consulting, clinical trials, laboratory services, and reimbursements, and this initiative aims to assist companies in managing these processes effectively.SMART Solutions aims to streamline operations and provide strategic guidance for MedTech companies amidst evolving regulatory landscapes.

## 相關資訊與研究

- [12:18 ETEurope faces a growing chronic wound crisis - time to act is now](https://longbridge.com/zh-HK/news/281218375.md)
- [Carl Zeiss Meditec (XTRA:AFX) Valuation After Expanded Canadian Ophthalmology Workflow Suite](https://longbridge.com/zh-HK/news/281471624.md)
- [Goldman Sachs Sticks to Their Buy Rating for Royal KPN NV (0O8F)](https://longbridge.com/zh-HK/news/281350991.md)
- [Bluesight Launches Redesigned 340BCheck Platform as Compliance Demands Intensify](https://longbridge.com/zh-HK/news/281364266.md)
- [Keller Group Updates Share Capital and Voting Rights for Regulatory Disclosures](https://longbridge.com/zh-HK/news/281338666.md)